| 1 |
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries[J]. JAMA, 2016, 315 (8): 788-800.
|
| 2 |
Rubenfeld GD, Caldwell E, Peabody E, et al. Inciden-ce and outcomes of acute lung injury[J]. N Engl J Med, 2005, 353 (16): 1685-1693.
|
| 3 |
Duggal A, Ganapathy A, Ratnapalan M, et al. Pharma-cological treatments for acute respiratory distress syndrome: systematic review[J]. Minerva Anestesiol, 2015, 81 (5): 567-588.
|
| 4 |
Horie S, Masterson C, Devaney J, et al. Stem cell therapy for acute respiratory distress syndrome: a promising future?[J]. Curr Opin Crit Care, 2016, 22 (1): 14-20.
|
| 5 |
Gupta N, Su X, Popov B, et al. Intrapulmonary deli-very of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice[J]. J Immunol, 2007, 179 (3): 1855-1863.
|
| 6 |
Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E.coli endotoxin-induced acute lung injury in the ex vivo perfused human lung[J]. Proc Natl Acad Sci U S A, 2009, 106 (38): 16357-16362.
|
| 7 |
Gyorgy B, Szabó TG, Pásztói M, et al. Membrane ves-icles, current state-of-the-art: emerging role of extracellular vesicles[J]. Cell Mol Life Sci, 2011, 68 (16): 2667-2688.
|
| 8 |
Zheng G, Huang R, Qiu G, et al. Mesenchymal strom-al cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis[J]. Cell Tissue Res, 2018, 374 (1): 1-15.
|
| 9 |
Holm MM, Kaiser J, Schwab ME. Extracellular vesicl-es: multimodal envoys in neural maintenance and repair[J]. Trends Neurosci, 2018, 41 (6): 360-372.
|
| 10 |
Shah TG, Predescu D, Predescu S. Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options[J]. Clin Trans Med, 2019, 8 (1): 25.
|
| 11 |
Mokarizadeh A, Delirezh N, Morshedi A, et al. Micro-vesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling[J]. Immunol Lett, 2012, 147 (1-2): 47-54.
|
| 12 |
Ramos TL, Sánchez-Abarca LI, Muntión S, et al. MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry[J]. Cell Commun Signal, 2016 (14): 2.
|
| 13 |
Kim HS, Choi DY, Yun SJ, et al. Proteomic analysis of microvesicles derived from human mesenchymal stem cells[J]. J Proteome Res, 2012, 11 (2): 839-849.
|
| 14 |
Burrello J, Monticone S, Gai C, et al. Stem cell-derived extracellular vesicles and immune-modulation[J]. Front Cell Dev Biol, 2016 (4): 83.
|
| 15 |
Tomasoni S, Longaretti L, Rota C, et al. Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells[J]. Stem Cells, 2013, 22 (5): 772-780.
|
| 16 |
Chen W, Huang Y, Han J, et al. Immunomodulatory effects of mesenchymal stromal cells-derived exosome[J]. Immunol Res, 2016, 64 (4): 831-840.
|
| 17 |
Ionescu L, Byrne RN, van Haaften T, et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action[J]. Am J Physiol Lung Cell Mol Physiol, 2012, 303 (11): L967-L977.
|
| 18 |
Walter J, Ware LB, Matthay MA. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis[J]. Lancet Respir Med, 2014, 2 (12): 1016-1026.
|
| 19 |
胡海，王珊，何丹，等. 间充质干细胞治疗脓毒症相关性急性肺损伤的研究进展[J/CD]. 中华危重症医学杂志（电子版），2020，13(2):141-144.
|
| 20 |
Lo Sicco C, Reverberi D, Balbi C, et al. Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: endorsement of macrophage polarization[J]. Stem Cells Transl Med, 2017, 6 (3): 1018-1028.
|
| 21 |
Morrison TJ, Jackson MV, Cunningham EK, et al. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer[J]. Am J Respir Crit Care Med, 2017, 196 (10): 1275-1286.
|
| 22 |
Hu S, Park J, Liu A, et al. Mesenchymal stem cell microvesicles restore protein permeability across primary cultures of injured human lung microvascular endothelial cells[J]. Stem Cells Transl Med, 2018, 7 (8): 615-624.
|
| 23 |
Monsel A, Zhu YG, Gennai S, et al. Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice[J]. Am J Respir Crit Care Med, 2015, 192 (3): 324-336
|
| 24 |
Zhu YG, Feng XM, Abbott J, et al. Human mesen-chymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice[J]. Stem Cells, 2014, 32 (1): 116-125.
|
| 25 |
Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2001, 163 (6): 1376-1383.
|
| 26 |
Park J, Kim S, Lim H, et al. Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia[J]. Thorax, 2019, 74 (1): 43-50.
|
| 27 |
Mahida RY, Matsumoto S, Matthay MA. Extracellular vesicles: a new frontier for research in acute respiratory distress syndrome[J]. J Respir Cell Mol Biol, 2020, 63 (1): 15-24.
|
| 28 |
Khatri M, Richardson LA, Meulia T. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model[J]. Stem Cell Res Ther, 2018, 9 (1): 17.
|
| 29 |
Huang R, Qin C, Wang J, et al. Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury[J]. Aging (Albany NY), 2019, 11 (18): 7996-8014.
|
| 30 |
Moschos SA, Williams AE, Perry MM, et al. Expre-ssion profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids[J]. BMC Genomics, 2007 (8): 240.
|
| 31 |
Park J, Jeong S, Park K, et al. Expression profile of microRNAs following bone marrow-derived mesenchymal stem cell treatment in lipopolysaccharide-induced acute lung injury[J]. Exp Ther Med, 2018, 15 (6): 5495-5502.
|
| 32 |
Wu X, Wu C, Gu W, et al. Serum exosomal microRNAs predict acute respiratory distress syndrome events in patients with severe community-acquired pneumonia[J]. Biomed Res Int, 2019: 3612020.
|
| 33 |
Yi X, Wei X, Lv H, et al. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3[J]. Exp Cell Res, 2019, 383 (2): 111454.
|
| 34 |
Li JW, Wei L, Han Z, et al. Mesenchymal stromal cells-derived exosomes alleviate ischemia / reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p[J]. Eur J Pharmacol, 2019 (852): 68-76.
|
| 35 |
Krasnodembskaya A, Samarani G, Song Y, et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes[J]. Am J Physiol Lung Cell Mol Physiol, 2012, 302 (10): L1003-L1013.
|
| 36 |
Li X, Zhang Y, Yeung SC, et al. Mitochondrial tran-sfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage[J]. Am J Respir Cell Mol Biol, 2014, 51 (3): 455-465.
|
| 37 |
Phinney DG, Di Giuseppe M, Njah J, et al. Mesen-chymal stem cells use extracellular vesicles to outsource mitophagy and shuttle micro-RNAs[J]. Nat Commun, 2015 (6): 8472.
|
| 38 |
Chen J, Chen L. Late-breaking abstract: human mese-nchymal stem cell exosomes attenuate sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway[J]. Eur Respir J, 2015 (46): OA4471.
|
| 39 |
Bardita C, Predescu D, Justice MJ, et al. In vivo knockdown of intersectin-1s alters endothelial cell phenotype and causes microvascular remodeling in the mouse lungs[J]. Apoptosis, 2013, 18 (1): 57-76.
|
| 40 |
Shah T, Qin S, Vashi M, et al. Alk5 / Runx1 signaling mediated by extracellular vesicles promotes vascular repair in acute respiratory distress syndrome[J]. Clin Transl Med, 2018, 7 (1): 19.
|
| 41 |
Silva JD, de Castro LL, Braga CL, et al. Mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology[J]. Stem Cells Int, 2019 (2019): 8262849.
|
| 42 |
Nowakowski A, Drela K, Rozycka J, et al. Engineered mesenchymal stem cells as an anti-cancer trojan horse[J]. Stem Cells Dev, 2016, 25 (20): 1513-1531.
|